LONDON - Archimedes Pharma Ltd. completed the biggest fundraising by a private European biotech in 15 years, raising £65 million (US$96.9 million) to set up U.S. operations and begin commercialization of PecFent, a fast-onset nasal formulation of the pain killer fentanyl. (BioWorld International) Read More
